Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2417857
Max Phase: Preclinical
Molecular Formula: C18H18N4O3S
Molecular Weight: 370.43
Molecule Type: Small molecule
Associated Items:
ID: ALA2417857
Max Phase: Preclinical
Molecular Formula: C18H18N4O3S
Molecular Weight: 370.43
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Cc1ccc(/C=N/NC(=S)Nc2ccc(C(=O)NCC(=O)O)cc2)cc1
Standard InChI: InChI=1S/C18H18N4O3S/c1-12-2-4-13(5-3-12)10-20-22-18(26)21-15-8-6-14(7-9-15)17(25)19-11-16(23)24/h2-10H,11H2,1H3,(H,19,25)(H,23,24)(H2,21,22,26)/b20-10+
Standard InChI Key: HAVDLCCJLMGFMF-KEBDBYFISA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 370.43 | Molecular Weight (Monoisotopic): 370.1100 | AlogP: 2.13 | #Rotatable Bonds: 6 |
Polar Surface Area: 102.82 | Molecular Species: ACID | HBA: 4 | HBD: 4 |
#RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 3.43 | CX Basic pKa: 2.26 | CX LogP: 2.75 | CX LogD: -0.43 |
Aromatic Rings: 2 | Heavy Atoms: 26 | QED Weighted: 0.35 | Np Likeness Score: -1.76 |
1. El-Sharief MA, Abbas SY, El-Bayouki KA, El-Bayouki KA, El-Gammal EW.. (2013) Synthesis of thiosemicarbazones derived from N-(4-hippuric acid)thiosemicarbazide and different carbonyl compounds as antimicrobial agents., 67 [PMID:23871906] [10.1016/j.ejmech.2013.06.031] |
Source(1):